메뉴 건너뛰기
Antimicrobial Agents and Chemotherapy
Volumn 59, Issue 2, 2015, Pages 1365-1369
Synergistic activity of chloroquine with fluconazole against fluconazole-resistant isolates of Candida species
Author keywords

[No Author keywords available]
Indexed keywords

CHLOROQUINE; FLUCONAZOLE; ANTIFUNGAL AGENT;
EID: 84921814739     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04417-14     Document Type: Article
Times cited : (23)
References (40)
  • 2
    • 33646046213 scopus 로고    scopus 로고
    • Epidemiology of Candida albicans infections and role of non-Candida albicans yeasts
    • Ruhnke M. 2006. Epidemiology of Candida albicans infections and role of non-Candida albicans yeasts. Curr Drug Targets 7:495-504. http://dx.doi .org/10.2174/138945006776359421.
    • (2006) Curr Drug Targets , vol.7 , pp. 495-504
    • Ruhnke, M.1
  • 3
    • 78751683832 scopus 로고    scopus 로고
    • Emerging opportunistic yeast infections
    • Miceli MH, Díaz JA, Lee SA. 2011. Emerging opportunistic yeast infections. Lancet Infect Dis 11:142-151. http://dx.doi.org/10.1016/S1473 -3099(10)70218-8.
    • (2011) Lancet Infect Dis , vol.11 , pp. 142-151
    • Miceli, M.H.1    Díaz, J.A.2    Lee, S.A.3
  • 4
    • 67650433788 scopus 로고    scopus 로고
    • Overview of the changing epidemiology of candidemia
    • Lewis RE. 2009. Overview of the changing epidemiology of candidemia. Curr Med Res Opin 25:1732-1740. http://dx.doi.org/10.1185/030079909 02990817.
    • (2009) Curr Med Res Opin , vol.25 , pp. 1732-1740
    • Lewis, R.E.1
  • 5
    • 79953181947 scopus 로고    scopus 로고
    • Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study
    • Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators
    • Kett DH, Azoulay E, Echeverria PM, Vincent JL; Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators. 2011. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 39:665-670. http://dx.doi.org/10.1097/CCM.0b013e318206c1ca.
    • (2011) Crit Care Med , vol.39 , pp. 665-670
    • Kett, D.H.1    Azoulay, E.2    Echeverria, P.M.3    Vincent, J.L.4
  • 6
    • 38849127419 scopus 로고    scopus 로고
    • Candidemia and candiduria in critically ill patients admitted to intensive care units in France: Incidence, molecular diversity, management and outcome
    • CandiRea Study Group
    • Bougnoux ME, Kac G, Aegerter P, d'Enfert C, Fagon JY; CandiRea Study Group. 2008. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med 34:292-299. http://dx.doi .org/10.1007/s00134-007-0865-y.
    • (2008) Intensive Care Med , vol.34 , pp. 292-299
    • Bougnoux, M.E.1    Kac, G.2    Aegerter, P.3    D'Enfert, C.4    Fagon, J.Y.5
  • 7
    • 67650508061 scopus 로고    scopus 로고
    • Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005-2006)
    • AmarCand Study Group
    • Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O; AmarCand Study Group. 2009. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 37: 1612-1618. http://dx.doi.org/10.1097/CCM.0b013e31819efac0.
    • (2009) Crit Care Med , vol.37 , pp. 1612-1618
    • Leroy, O.1    Gangneux, J.P.2    Montravers, P.3    Mira, J.P.4    Gouin, F.5    Sollet, J.P.6    Carlet, J.7    Reynes, J.8    Rosenheim, M.9    Regnier, B.10    Lortholary, O.11
  • 8
    • 69049100062 scopus 로고    scopus 로고
    • Determinants of mortality in non-neutropenic ICU patients with candidaemia
    • Australian Candidaemia Study.
    • Marriott DJ, Playford EG, Chen S, Slavin M, Nguyen Q, Ellis D, Sorrell TC; Australian Candidaemia Study. 2009. Determinants of mortality in non-neutropenic ICU patients with candidaemia. Crit Care 13:R115. http: //dx.doi.org/10.1186/cc7964.
    • (2009) Crit Care , vol.13 , pp. R115
    • Marriott, D.J.1    Playford, E.G.2    Chen, S.3    Slavin, M.4    Nguyen, Q.5    Ellis, D.6    Sorrell, T.C.7
  • 9
    • 80052823854 scopus 로고    scopus 로고
    • Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy
    • Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C.2011. Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS One 6:e24198. http://dx.doi.org/10.1371/journal.pone.0024198.
    • (2011) PLoS One , vol.6 , pp. e24198
    • Bassetti, M.1    Taramasso, L.2    Nicco, E.3    Molinari, M.P.4    Mussap, M.5    Viscoli, C.6
  • 11
    • 84876089804 scopus 로고    scopus 로고
    • Antifungal activity of geldanamycin alone or in combination with fluconazole against Candida species
    • Zhang J, Liu W, Tan J, Sun Y, Wan Z, Li R. 2013. Antifungal activity of geldanamycin alone or in combination with fluconazole against Candida species. Mycopathologia 175:273-279. http://dx.doi.org/10.1007/s11046 -012-9612-1.
    • (2013) Mycopathologia , vol.175 , pp. 273-279
    • Zhang, J.1    Liu, W.2    Tan, J.3    Sun, Y.4    Wan, Z.5    Li, R.6
  • 12
    • 77951237516 scopus 로고    scopus 로고
    • Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans
    • Gamarra S, Rocha EM, Zhang YQ, Park S, Rao R, Perlin DS. 2010.Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans. Antimicrob Agents Chemother 54:1753-1761. http://dx .doi.org/10.1128/AAC.01728-09.
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 1753-1761
    • Gamarra, S.1    Rocha, E.M.2    Zhang, Y.Q.3    Park, S.4    Rao, R.5    Perlin, D.S.6
  • 13
    • 33644650719 scopus 로고    scopus 로고
    • Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole
    • Quan H, Cao YY, Xu Z, Zhao JX, Gao PH, Qin XF, Jiang YY. 2006. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrob Agents Chemother 50: 1096-1099. http://dx.doi.org/10.1128 /AAC.50.3.1096-1099.2006.
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 1096-1099
    • Quan, H.1    Cao, Y.Y.2    Xu, Z.3    Zhao, J.X.4    Gao, P.H.5    Qin, X.F.6    Jiang, Y.Y.7
  • 14
    • 0034896166 scopus 로고    scopus 로고
    • Rationale for combination antifungal therapy
    • Lewis RE, Kontoyiannis DP. 2001. Rationale for combination antifungal therapy. Pharmacotherapy 21: 149S-164S. http://dx.doi.org/10.1592 /phco.21.12.149S.34505.
    • (2001) Pharmacotherapy , vol.21 , pp. 149S-164S
    • Lewis, R.E.1    Kontoyiannis, D.P.2
  • 16
    • 18744386931 scopus 로고    scopus 로고
    • PKSP-dependent reduction of phagolysosome fusion and intracellular kill of Aspergillus fumigatus conidia by human monocyte-derived macrophages
    • Jahn B, Langfelder K, Schneider U, Schindel C, Brakhage AA. 2002. PKSP-dependent reduction of phagolysosome fusion and intracellular kill of Aspergillus fumigatus conidia by human monocyte-derived macrophages. Cell Microbiol 4:793-803. http://dx.doi.org/10.1046/j.1462-5822 .2002.00228.x.
    • (2002) Cell Microbiol , vol.4 , pp. 793-803
    • Jahn, B.1    Langfelder, K.2    Schneider, U.3    Schindel, C.4    Brakhage, A.A.5
  • 17
    • 0030824696 scopus 로고    scopus 로고
    • Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation
    • Levitz SM, Harrison TS, Tabuni A, Liu XP. 1997. Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation. J Clin Invest 100: 1640-1646. http://dx.doi.org/10.1172/JCI119688.
    • (1997) J Clin Invest , vol.100 , pp. 1640-1646
    • Levitz, S.M.1    Harrison, T.S.2    Tabuni, A.3    Liu, X.P.4
  • 18
    • 34548460117 scopus 로고    scopus 로고
    • Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century
    • st century. Int J Antimicrob Agents 30:297-308. http://dx.doi.org/10.1016/j .ijantimicag.2007.05.015.
    • (2007) Int J Antimicrob Agents , vol.30 , pp. 297-308
    • Rolain, J.M.1    Colson, P.2    Raoult, D.3
  • 19
    • 56949096142 scopus 로고    scopus 로고
    • Fungal adaptation to the mammalian host: It is a new world, after all
    • Cooney NM, Klein BS. 2008. Fungal adaptation to the mammalian host: it is a new world, after all. Curr Opin Microbiol 11:511-516. http://dx.doi .org/10.1016/j.mib.2008.09.018.
    • (2008) Curr Opin Microbiol , vol.11 , pp. 511-516
    • Cooney, N.M.1    Klein, B.S.2
  • 20
    • 84878837712 scopus 로고    scopus 로고
    • An in vitro repositioning study reveals antifungal potential of chloroquine to inhibit growth and morphogenesis in Candida albicans
    • Shinde RB, Rajput SB, Raut JS, Karuppayil SM. 2013. An in vitro repositioning study reveals antifungal potential of chloroquine to inhibit growth and morphogenesis in Candida albicans. J Gen Appl Microbiol 59:167-170. http://dx.doi.org/10.2323/jgam.59.167.
    • (2013) J Gen Appl Microbiol , vol.59 , pp. 167-170
    • Shinde, R.B.1    Rajput, S.B.2    Raut, J.S.3    Karuppayil, S.M.4
  • 21
    • 84880939734 scopus 로고    scopus 로고
    • Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles
    • Shinde RB, Raut JS, Chauhan NM, Karuppayil SM. 2013. Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles. Braz J Infect Dis 17:395-400. http://dx.doi.org/10.1016/j.bjid.2012.11.002.
    • (2013) Braz J Infect Dis , vol.17 , pp. 395-400
    • Shinde, R.B.1    Raut, J.S.2    Chauhan, N.M.3    Karuppayil, S.M.4
  • 22
    • 33644912365 scopus 로고    scopus 로고
    • Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions
    • Leaw SN, Chang HC, Sun HF, Barton R, Bouchara JP, Chang TC. 2006. Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol 44:693-699. http: //dx.doi.org/10.1128/JCM.44.3.693-699.2006.
    • (2006) J Clin Microbiol , vol.44 , pp. 693-699
    • Leaw, S.N.1    Chang, H.C.2    Sun, H.F.3    Barton, R.4    Bouchara, J.P.5    Chang, T.C.6
  • 24
    • 84864523178 scopus 로고    scopus 로고
    • In vitro antifungal susceptibility of filamentous fungi causing rare infections: Synergy testing of amphotericin B, posaconazole and anidulafungin in pairs
    • Drogari-Apiranthitou M, Mantopoulou FD, Skiada A, Kanioura L, Grammatikou M, Vrioni G, Mitroussia-Ziouva A, Tsakris A, Petrikkos G. 2012. In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs. J Antimicrob Chemother 67:1937-1940. http://dx.doi.org /10.1093/jac/dks137. Downloaded from http://aac.asm.org/ on January 27, 2015 by Elsevier Bibliographic Databases
    • (2012) J Antimicrob Chemother , vol.67 , pp. 1937-1940
    • Drogari-Apiranthitou, M.1    Mantopoulou, F.D.2    Skiada, A.3    Kanioura, L.4    Grammatikou, M.5    Vrioni, G.6    Mitroussia-Ziouva, A.7    Tsakris, A.8    Petrikkos, G.9
  • 25
    • 0038601510 scopus 로고    scopus 로고
    • Synergy, antagonism, and what the chequerboard puts between them
    • Odds FC. 2003. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52:1. http://dx.doi.org/10.1093 /jac/dkg301.
    • (2003) J Antimicrob Chemother , vol.52 , pp. 1
    • Odds, F.C.1
  • 27
    • 0029895127 scopus 로고    scopus 로고
    • Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates
    • Pfaller MA, Messer SA, Bolmström A, Odds FC, Rex JH. 1996. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol 34:1691-1693.
    • (1996) J Clin Microbiol , vol.34 , pp. 1691-1693
    • Pfaller, M.A.1    Messer, S.A.2    Bolmström, A.3    Odds, F.C.4    Rex, J.H.5
  • 28
    • 0036178010 scopus 로고    scopus 로고
    • Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species
    • Lewis RE, Diekema DJ, Messer SA, Pfaller MA, Klepser ME. 2002. Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. J Antimicrob Chemother 49:345-351. http://dx .doi.org/10.1093/jac/49.2.345.
    • (2002) J Antimicrob Chemother , vol.49 , pp. 345-351
    • Lewis, R.E.1    Diekema, D.J.2    Messer, S.A.3    Pfaller, M.A.4    Klepser, M.E.5
  • 30
    • 0028350193 scopus 로고
    • Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis
    • Newman SL, Gootee L, Brunner G, Deepe GS, Jr. 1994. Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest 93:1422-1429. http://dx.doi.org/10.1172 /JCI117119.
    • (1994) J Clin Invest , vol.93 , pp. 1422-1429
    • Newman, S.L.1    Gootee, L.2    Brunner, G.3    Deepe, G.S.4
  • 31
    • 0036174441 scopus 로고    scopus 로고
    • Relationship between chloroquine toxicity and iron acquisition in Saccharomyces cerevisiae
    • Emerson LR, Nau ME, Martin RK, Kyle DE, Vahey M, Wirth DF. 2002. Relationship between chloroquine toxicity and iron acquisition in Saccharomyces cerevisiae. Antimicrob Agents Chemother 46:787-796. http://dx .doi.org/10.1128/AAC.46.3.787-796.2002.
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 787-796
    • Emerson, L.R.1    Nau, M.E.2    Martin, R.K.3    Kyle, D.E.4    Vahey, M.5    Wirth, D.F.6
  • 32
    • 33750601648 scopus 로고    scopus 로고
    • Unexpected link between iron and drug resistance of Candida spp.: Iron depletion enhances membrane fluidity and drug diffusion, leading to drugsusceptible cells
    • Prasad T, Chandra A, Mukhopadhyay CK, Prasad R. 2006. Unexpected link between iron and drug resistance of Candida spp.: iron depletion enhances membrane fluidity and drug diffusion, leading to drugsusceptible cells. Antimicrob Agents Chemother 50:3597-3606. http://dx .doi.org/10.1128/AAC.00653-06.
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 3597-3606
    • Prasad, T.1    Chandra, A.2    Mukhopadhyay, C.K.3    Prasad, R.4
  • 34
    • 0036488166 scopus 로고    scopus 로고
    • Resistance of Candida species to antifungal agents: Molecular mechanisms and clinical consequences
    • Sanglard D, Odds FC. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2:73-85. http://dx.doi.org/10.1016/S1473-3099(02)00181-0.
    • (2002) Lancet Infect Dis , vol.2 , pp. 73-85
    • Sanglard, D.1    Odds, F.C.2
  • 36
    • 0026659564 scopus 로고
    • Antimalarial pharmacokinetics and treatment regimens
    • White NJ. 1992. Antimalarial pharmacokinetics and treatment regimens. Br J Clin Pharmacol 34:1-10. http://dx.doi.org/10.1111/j.1365-2125.1992 .tb04100.x.
    • (1992) Br J Clin Pharmacol , vol.34 , pp. 1-10
    • White, N.J.1
  • 38
    • 84885453391 scopus 로고    scopus 로고
    • Model system to define pharmacokinetic requirements for antimalarial drug efficacy
    • Bakshi RP, Nenortas E, Tripathi AK, Sullivan DJ, Shapiro TA. 2013. Model system to define pharmacokinetic requirements for antimalarial drug efficacy. Sci Transl Med 5:205ra135. http://dx.doi.org/10.1126 /scitranslmed.3006684.
    • (2013) Sci Transl Med , vol.5 , pp. 205ra135
    • Bakshi, R.P.1    Nenortas, E.2    Tripathi, A.K.3    Sullivan, D.J.4    Shapiro, T.A.5
  • 39
    • 79960322124 scopus 로고    scopus 로고
    • Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model
    • Moore BR, Page-Sharp M, Stoney JR, Ilett KF, Jago JD, Batty KT. 2011. Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model. Antimicrob Agents Chemother 55: 3899-3907. http://dx.doi.org/10.1128/AAC.00067-11.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 3899-3907
    • Moore, B.R.1    Page-Sharp, M.2    Stoney, J.R.3    Ilett, K.F.4    Jago, J.D.5    Batty, K.T.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.